HEADER TRANSFERASE 15-JAN-16 5HLW TITLE CRYSTAL STRUCTURE OF C-MET MUTANT Y1230H IN COMPLEX WITH COMPOUND 14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, TRANSFERASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR F.VALLEE,S.POUZIEUX,J.P.MARQUETTE,J.HOUTMANN REVDAT 1 23-NOV-16 5HLW 0 JRNL AUTH A.UGOLINI,M.KENIGSBERG,A.RAK,F.VALLEE,J.HOUTMANN,M.LOWINSKI, JRNL AUTH 2 C.CAPDEVILA,J.KHIDER,E.ALBERT,N.MARTINET,C.NEMECEK, JRNL AUTH 3 S.GRAPINET,E.BACQUE,M.ROESNER,C.DELAISI,L.CALVET,F.BONCHE, JRNL AUTH 4 D.SEMIOND,C.EGILE,H.GOULAOUIC,L.SCHIO JRNL TITL DISCOVERY AND PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES JRNL TITL 2 OF THE POTENT AND SELECTIVE MET KINASE INHIBITOR JRNL TITL 3 1-{6-[6-(4-FLUOROPHENYL)-[1,2,4]TRIAZOLO[4, JRNL TITL 4 3-B]PYRIDAZIN-3-YLSULFANYL]BENZOTHIAZOL-2-YL}-3-(2-MORPHOLIN JRNL TITL 5 -4-YLETHYL)UREA (SAR125844). JRNL REF J.MED.CHEM. V. 59 7066 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27355974 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00280 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 22929 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1175 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2793 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2025 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2635 REMARK 3 BIN R VALUE (WORKING SET) : 0.1996 REMARK 3 BIN FREE R VALUE : 0.2538 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.66 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 158 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2249 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.32660 REMARK 3 B22 (A**2) : 4.90320 REMARK 3 B33 (A**2) : -2.57660 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.201 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.172 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.144 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.161 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.140 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2345 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3173 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 796 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 44 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 370 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2345 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 295 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2859 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.48 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HLW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217283. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-09 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21753 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 34.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS 100MM-MPD20%-PH8, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.66000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.48000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.34500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.48000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.66000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.34500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1073 REMARK 465 GLY A 1087 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 THR A 1116 REMARK 465 LEU A 1147 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A1074 OG REMARK 470 HIS A1088 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A1099 CG OD1 OD2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 ILE A1115 CG1 CG2 CD1 REMARK 470 ASP A1117 CG OD1 OD2 REMARK 470 SER A1152 OG REMARK 470 VAL A1237 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1089 -151.37 -156.46 REMARK 500 LYS A1103 149.93 -170.16 REMARK 500 ASN A1113 -112.92 -7.18 REMARK 500 ARG A1114 78.78 -157.55 REMARK 500 ARG A1203 -18.18 79.89 REMARK 500 ALA A1221 -153.14 -116.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 62E A 1402 DBREF 5HLW A 1057 1355 UNP P08581 MET_HUMAN 1057 1355 SEQADV 5HLW HIS A 1230 UNP P08581 TYR 1230 ENGINEERED MUTATION SEQRES 1 A 299 ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL SEQRES 2 A 299 VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE ASN GLU SEQRES 3 A 299 VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY SEQRES 4 A 299 THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA SEQRES 5 A 299 VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SEQRES 6 A 299 SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS ASP PHE SEQRES 7 A 299 SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE CYS LEU SEQRES 8 A 299 ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO TYR MET SEQRES 9 A 299 LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU THR SEQRES 10 A 299 HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE GLY LEU SEQRES 11 A 299 GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER LYS LYS SEQRES 12 A 299 PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 13 A 299 ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 14 A 299 ALA ARG ASP MET HIS ASP LYS GLU TYR TYR SER VAL HIS SEQRES 15 A 299 ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP MET ALA SEQRES 16 A 299 LEU GLU SER LEU GLN THR GLN LYS PHE THR THR LYS SER SEQRES 17 A 299 ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU LEU MET SEQRES 18 A 299 THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN THR PHE SEQRES 19 A 299 ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU SEQRES 20 A 299 GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL MET SEQRES 21 A 299 LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG PRO SER SEQRES 22 A 299 PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE PHE SER SEQRES 23 A 299 THR PHE ILE GLY GLU HIS TYR VAL HIS VAL ASN ALA THR HET CL A1401 1 HET 62E A1402 38 HETNAM CL CHLORIDE ION HETNAM 62E 1-[2-(1-ETHYLPIPERIDIN-4-YL)ETHYL]-3-(6-{[6-(THIOPHEN- HETNAM 2 62E 2-YL)[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-3-YL]SULFANYL}-1, HETNAM 3 62E 3-BENZOTHIAZOL-2-YL)UREA FORMUL 2 CL CL 1- FORMUL 3 62E C26 H28 N8 O S3 FORMUL 4 HOH *192(H2 O) HELIX 1 AA1 ASN A 1059 VAL A 1066 1 8 HELIX 2 AA2 ILE A 1118 ASP A 1133 1 16 HELIX 3 AA3 LEU A 1165 ASN A 1171 1 7 HELIX 4 AA4 THR A 1177 LYS A 1198 1 22 HELIX 5 AA5 ALA A 1206 ARG A 1208 5 3 HELIX 6 AA6 PHE A 1223 ARG A 1227 5 5 HELIX 7 AA7 PRO A 1246 MET A 1250 5 5 HELIX 8 AA8 ALA A 1251 GLN A 1258 1 8 HELIX 9 AA9 THR A 1261 THR A 1278 1 18 HELIX 10 AB1 ASN A 1288 PHE A 1290 5 3 HELIX 11 AB2 ASP A 1291 GLN A 1298 1 8 HELIX 12 AB3 PRO A 1309 TRP A 1320 1 12 HELIX 13 AB4 LYS A 1323 ARG A 1327 5 5 HELIX 14 AB5 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 ILE A1077 GLY A1085 0 SHEET 2 AA1 5 CYS A1091 LEU A1097 -1 O VAL A1092 N ILE A1084 SHEET 3 AA1 5 ILE A1105 SER A1111 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 3 GLY A1163 ASP A1164 0 SHEET 2 AA2 3 CYS A1210 LEU A1212 -1 O LEU A1212 N GLY A1163 SHEET 3 AA2 3 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 4 LYS A1179 GLY A1346 GLU A1347 HIS A1348 SITE 1 AC2 14 ILE A1084 ALA A1108 LEU A1157 PRO A1158 SITE 2 AC2 14 TYR A1159 MET A1160 LYS A1161 GLY A1163 SITE 3 AC2 14 MET A1211 ALA A1221 ASP A1222 ALA A1226 SITE 4 AC2 14 HIS A1230 HOH A1624 CRYST1 43.320 46.690 156.960 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023084 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021418 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006371 0.00000